Aspen Pharmacare Holdings Limited
Climate Impact & Sustainability Data (2013, 2015, 2017, 2018, 2020-07 to 2021-06, 2021, 2022, 2023)
Reporting Period: 2013
Environmental Metrics
ESG Focus Areas
- Occupational health, safety, and environment management
- Corporate social responsibility
- BBBEE (Broad-Based Black Economic Empowerment)
- Sustainability
Environmental Achievements
- South African sites achieved ISO 14001 and OHSAS 18001 certifications.
- Aspen Bad Oldesloe site maintained ISO 14001 and OHSAS 18001 certification.
Social Achievements
- Nelson Mandela International Day reached approximately 9,400 beneficiaries.
- Aspen played a leading role in forming the Public Healthcare Enhancement Fund in South Africa.
- Aspen became an active participant in the United Nations Global Compact.
Governance Achievements
- Aspen’s Sustainability Report was externally assured for the first time.
- Further incremental enhancements were made to the Group’s governance processes, including the appointment of Regional Ethics Officers.
Climate Goals & Targets
Environmental Challenges
- Intense competition in the global pharmaceutical market.
- Stringent regulation and application of quality standards.
- Market diversity increasing variability of customer expectations and supply chain complexities.
- Delayed approval of API source changes.
- Evolving regulatory requirements and product regulations.
- Advent of the Falsified Medicines Directive in Europe.
- Publication of European Union distribution guidelines.
- Divergent Human Resource practices and SHE standards throughout the Group.
- Lack of an integrated Human Resources Management System.
- Onerous reporting and disclosure requirements in respect of Aspen’s corporate citizenship.
- Acquired businesses come with their own organizational cultures requiring alignment with Aspen’s culture.
- Completion of proposed transactions subject to conditions precedent, including approval of various competition authorities.
- Revised Department of Trade & Industry’s BBBEE Codes may lead to a less favorable BBBEE rating.
Mitigation Strategies
- Various transactions to increase product offering and geographic coverage.
- Group supply chain head appointed to review and manage efficiency and integrity of the global supply chain.
- Group supply chain portal commissioned for enhanced communication.
- Group Quality Department established to monitor and manage quality risk.
- Remediation plans implemented to prevent recurrence of product recalls.
- Proactive material sourcing.
- Approximately 400 specialist sales personnel to transfer to Aspen for direct promotion of products.
- Over 300 new commercial employees to support acquired infant nutritional business.
- Sales teams in Brazil, Mexico, and Venezuela to be increased.
- Direct promotion of Aspen’s products increased in several markets.
- Development centre established in India to enhance capacity to maintain intellectual property cost-effectively.
- Supply chain automation project to improve supply chain efficiencies.
- Addressing divergent Human Resource practices and SHE standards.
- Change management programs to assist in the integration of acquired businesses.
- Embedding principles of good corporate governance in business practices.
- Mandela Day initiative retained as an annual event.
- Building infrastructure and resources ahead of completion of proposed transactions.
- Divestiture of non-core products/businesses to be considered.
Supply Chain Management
Responsible Procurement
- Centralised procurement leading to benefits in sourcing raw materials and products
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI (Global Reporting Initiative) B+ application level, King III
Certifications: ISO 14001, OHSAS 18001, ISO 22000, HACCP
Third-party Assurance: Environmental Resources Management, PricewaterhouseCoopers Inc.
Awards & Recognition
- Best generics manufacturer (Soweto General Practitioner Confidence Predictor survey)
- Generic Supplier of the Year (Sigma Supplier Awards)
- Supplier of the Year 2013 Award (Discount Drug Store)
- Generic Supplier of the Year Award (Inaugural Sigma Supplier Awards)
- Kidspot Best Baby Formula award (Australian parents)
- President’s Manufacturer of the Year Award (Tanzania)
- Golden Arrow Award (PMR.africa)
- Ireland INC Foreign Direct Investment 100 honorees
- Supplier of the Year award (Dis-Chem)
- Best Corporate Web Page (Aspid Award)
Reporting Period: 2015
Environmental Metrics
ESG Focus Areas
- Sustaining life and health through high-quality, affordable medicines
- Adding economic value to stakeholders
- Maintenance of financial health
- Sustaining a cost-competitive manufacturing base
- Providing a safe working environment
- Promoting equality
- Creating an environment in which our employees can thrive
- Contributing to the enhancement of healthcare, education and basic needs in communities
- Preserving the environment
- Managing the efficient utilisation of scarce resources
- Conducting our business in a responsible manner
Environmental Achievements
- Aspen Bad Oldesloe uses 100% renewable energy
- Improved waste recycling (883% increase, largely due to inclusion of new facilities)
Social Achievements
- Supported 263 socio-economic development (SED) projects valued at R20.5 million
- Launched Women in Leadership Programme
- Launched dairyman learnership programme including learners with disabilities
- Increased investment in employee training (63% increase)
Governance Achievements
- Continued compliance with JSE’s SRI index
- Executive compensation linked to financial, social, environmental, and governance aspects
Climate Goals & Targets
- Not disclosed
- Implementation of intensity-based measures for material KPIs
- Expand scope of Aspen’s CDP carbon and water submissions
- Setting targets for material KPIs
- Complete OHSAS 18001 alignment project by 2017
- Align environmental management systems at other manufacturing sites to ISO 14001 by 2017
Environmental Challenges
- Increased global economic pressure (volatile currency markets, price reductions, heightened regulation)
- Aging infrastructure at Moleneind and Boxtel sites in the Netherlands leading to safety and environmental compliance risks
- Soil contamination at Moleneind site (responsibility retained by previous owner, MSD)
- Spills at Moleneind site
- Changes to BBBEE Codes in South Africa impacting scorecard
- High staff turnover in some regions
- Electricity shortages in South Africa impacting manufacturing
- Water scarcity and aging infrastructure impacting water supply consistency
Mitigation Strategies
- Capital expansion projects in South Africa, France, and the Netherlands to improve supply chain and reduce costs
- Divestment of non-core brands and molecules
- Implementation of formal SHE management systems
- Proactive engagement with stakeholders and authorities in the Netherlands
- Revised transformational objectives and programs in South Africa to address BBBEE Code changes
- Interventions to address high staff turnover rates
- Energy conservation initiatives (e.g., LED lighting, SCADA system)
- Water conservation initiatives (e.g., water recycling, leak prevention)
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Procurement from accredited and authorized suppliers meeting quality, regulatory, and Aspen-specified requirements
- Suppliers bound by Aspen’s Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: GRI G3.0, JSE’s Socially Responsible Investment (SRI) index, International Integrated Reporting Council’s Framework, UN Global Compact
Certifications: OHSAS 18001 (selected sites), ISO 14001 (selected sites), ISO 50001 (Aspen Bad Oldesloe)
Third-party Assurance: Environmental Resources Management (Pty) Limited (ERM), PricewaterhouseCoopers Inc. (PwC)
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2017
Environmental Metrics
ESG Focus Areas
- Access to high quality, affordable medicines
- Integrated supply chain
- Employee well-being
- Corporate citizenship
- Sustainable economic value
Environmental Achievements
- 4.5% of waste generated sent to landfill, a reduction from 6.2% in 2016
- An estimated 97,000 kℓ of water saved through resource efficiency projects
- 8% increase in waste recycled
Social Achievements
- 84% participation rate in the global employee engagement survey
- R49.5 million invested in employee training
- 49% women in the workforce
- Zero work-related fatalities
- Maintained Level 4 BBBEE rating in South Africa
- More than 250 SED projects completed
Governance Achievements
- New Group Code of Marketing Practice rolled out
- 9,242 employees signed the Aspen Code of Conduct
- Improved rating on the JSE/FTSE Responsible Investment Index
Climate Goals & Targets
Environmental Challenges
- Pricing of oncology products under scrutiny
- Currency headwinds, price erosion, and constrained nutritionals sales
- Supply chain constraints
- Competition from biosimilars, generics, and oral products
- Challenges in transitioning the manufacture of Thyrax
- Changes in European distribution model
- Loss of Venezuelan volumes and Chinese regulatory restrictions on sales from Australia
- Increased scrutiny on pricing from competition authorities
- Supply shortages of mature products
- Evolving pharmaceutical regulations and stringent quality standards
- Competition in the global pharmaceutical market
- Volatile geopolitical and economic conditions
- Complexity of integrating acquired businesses
- Challenges in the Chinese market
Mitigation Strategies
- Proactive engagement with authorities in investigations
- Synergy projects to offset headwinds
- Focus on manufacturing efficiency and working capital management
- Strategic advantage from vertically integrated supply chain
- Progress in stabilizing API production of synthetic estrogens
- Improved supply chain in Latin America
- Reshaping portfolio in Australia to focus on value-adding brands
- Increased capacity in manufacturing facilities
- Upgrading older medicines to meet modern regulatory requirements
- Product and geographic diversification
- Focus on niche speciality pharmaceuticals
- Strong corporate governance, high ethical standards, and stakeholder-inclusive approach
- Initiatives to streamline global product portfolio
- New global HR strategy
- Continued investment in skills development
- Phased approach to ISO certification
- Reduction in chemical activity at Moleneind facility in Oss
- Full cooperation with competition authorities
- Continued investment in manufacturing capacity
- Focus on cost containment initiatives
- Strategic initiatives to diversify market risks, currency risks, and product risks
- Leveraging existing sales force and sterile manufacturing capabilities
- Strategic review of Nutritionals business
- Leveraging HPC launch in the USA and synthetic estrogen launch
Supply Chain Management
Responsible Procurement
- Aspen Supplier Code of Conduct
- Ethical and human rights standards
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI, King IV
Certifications: OHSAS 18001 (75% of primary manufacturing facilities and 29% of API facilities), ISO 14001 (75% of primary manufacturing facilities and 29% of API facilities)
Third-party Assurance: ERM, PwC, Group Internal Audit, Empowerdex
Reporting Period: 2018
Environmental Metrics
ESG Focus Areas
- Sustaining life and health through high quality, affordable medicines
- Sustaining a cost-competitive manufacturing base
- Creating an environment in which our employees can thrive
- Promoting equality
- Conducting our business in a responsible manner
- Preserving the environment
- Adding economic value to stakeholders
Environmental Achievements
- Reduced carbon emissions (Specific figures not readily available in the provided text, further data needed)
- Recycled 80,973 tonnes of waste (2018)
Social Achievements
- BBBEE accreditation Level 4 in South Africa (2018)
- Socio-economic development (SED) spend of R19.0 million (2018)
Governance Achievements
- Number of significant legislative infringements: 0 (2018)
- FTSE/JSE Responsible Investment Index score: 4.0 (2018)
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Not disclosed
Environmental Challenges
- Not disclosed
Mitigation Strategies
- Not disclosed
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: International Integrated Reporting Framework, GRI, King IV, Companies Act of South Africa, Department of Trade and Industry’s BBBEE Codes of Good Practice, FTSE/JSE Responsible Investment Index, Carbon and Water Security Disclosure Projects, UN Global Compact
Certifications: Null
Third-party Assurance: Environmental Resources Management (Pty) Limited (ERM), Empowerdex, PricewaterhouseCoopers (PwC)
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2020-07 to 2021-06
Environmental Metrics
ESG Focus Areas
- Climate Change
- Water Security
Environmental Achievements
- Reduced Scope 3 emissions from water supply services by 9%
- Reduced Scope 3 emissions from fuel-and-energy-related activities by 6%
- Reduced Scope 3 emissions from waste generated in operations significantly due to correction of a conversion error
- Reduced Scope 3 emissions from business travel significantly due to travel restrictions during the COVID-19 pandemic
- Reduced Scope 3 emissions from upstream leased assets by 22%
- A slight reduction of 1% in total waste generated
Social Achievements
- Not disclosed
Governance Achievements
- Board-level oversight of climate-related issues
- Establishment of a Group Risk and Sustainability function
- Development of a sustainability materiality assessment survey
Climate Goals & Targets
- Implement a ten-year Group target for emissions reduction (review in 2023)
- Achieve a moderate reduction in Scope 1 and Scope 2 emissions within the next 5 years
- Develop a clear position statement, absolute targets for emissions reduction, and a climate action strategy within the next two years
- Introduce an emissions target within the next two years
- Develop a transition plan within two years
- Conduct scenario analysis within the next two years
Environmental Challenges
- Increased indirect (operating) costs due to carbon pricing mechanisms in South Africa
- Increased capital expenditures due to the phase-out of refrigerants with high global warming potential
- Decreased access to capital due to increased stakeholder concern and negative stakeholder feedback
Mitigation Strategies
- Remaining abreast of legislative changes and implementing monitoring and control measures to minimize GHG emissions
- Replacing existing units with new units that use alternative refrigerants or converting existing units
- Developing a clear position statement, absolute targets for emissions reduction, and a climate action strategy
Supply Chain Management
Supplier Audits: 0%
Responsible Procurement
- Aspen Code of Conduct for Suppliers and Service Providers
Climate-Related Risks & Opportunities
Physical Risks
- Reduced precipitation and rising temperatures impacting water supply and security
Transition Risks
- Introduction of a carbon pricing system in South Africa and other jurisdictions
- Future potential requirements for carbon labelling
Opportunities
- Use of more efficient production and distribution processes
- Use of supportive policy incentives (e.g., tax refunds in Germany)
- Use of lower-emission sources of energy (e.g., solar energy)
Reporting Standards
Frameworks Used: TCFD, GHG Protocol
Certifications: ISO 14001, ISO 50001
Third-party Assurance: Aspen SD Assurance Statement 2021.pdf
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Safety
- Environmental
- Social
- Governance
Climate Goals & Targets
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: AA1000AP (2018), UN Global Compact, OECD Guidelines, SASB, UN SDGs
Third-party Assurance: IBIS Environmental Social Governance Consulting Africa (Pty) Ltd
UN Sustainable Development Goals
- Eight of the SDGs that most closely align with Aspen’s business have been adopted and reported on for FY2021
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Access to medicines
- Health security
- Patient safety
- Responsible advocacy and lobbying
- Responsible marketing
- Reliable supply of quality products
- Responsible product portfolio
- Diversity, equity and inclusion
- Employee health and safety
- Employee well-being
- Fair compensation
- Labour rights
- Workforce development
- Human rights
- Ethical business culture
- Compliance
- Corporate governance
- Transformation and economic inclusion (B-BBEE in South Africa)
- SED and investment in communities
- Economic value generated and distributed
- Fair taxation
- Responsible supply chain management
- Data privacy and information security
- Climate change and greenhouse gas emissions
- Energy efficiency
- Waste
- Water and effluent
Environmental Achievements
- 10% reduction in Scope 1 emissions
- 22% reduction in Scope 2 emissions
- 5% reduction in water withdrawn
- 80% of waste generated recycled
Social Achievements
- Women in top management roles increased to 34%
- R27.9 million invested in 355 socio-economic development projects
- Zero occupational fatalities since 2013
- Global employee engagement survey conducted with 68% response rate
Governance Achievements
- Strengthened Group Ethics and Compliance programme
- “B- Management” performance rating for 2021 Carbon Disclosure Project for Climate Change (“CDP-CC”) and “B Management” Carbon Disclosure Project for Water Security (“CDP-WS”)
Climate Goals & Targets
- Not disclosed
- Achieve the transfer of the manufacture of complex, sterile products to Aspen sites
- Further progress on Group human capital strategy
- Develop a climate change strategy
- Develop and implement an access to medicines strategy
- Secure sterile capacity fill opportunities by the end of FY2023
Environmental Challenges
- Supply chain disruptions due to COVID-19 and the fire at Alphamed facility
- Geopolitical situation in Russia/Ukraine
- Renewed lockdown in China impacting product demand
- Inflationary pressures and downward pressure on selling prices
- Evolving pharmaceutical regulations and stringent quality standards
Mitigation Strategies
- Strategic investment in inventory to mitigate supply risks
- Strong cost management controls
- Diversified product portfolio and geographical footprint
- Implementation of integrated business planning process
- Investment in sterile manufacturing capacity
Supply Chain Management
Responsible Procurement
- Aspen Code of Conduct for Suppliers and Service Providers
- Preferential procurement for B-BBEE recognized suppliers
Climate-Related Risks & Opportunities
Physical Risks
- Natural disasters
- Water scarcity
Transition Risks
- Changes in regulations to accelerate climate action
Opportunities
- Reduce carbon footprint
- Increase efficiencies in using scarce natural resources
- Build resilience against physical impacts
Reporting Standards
Frameworks Used: IFRS, IFRS Foundation International
Certifications: ISO 14001:2015, ISO 45001
Third-party Assurance: Ernst & Young Inc, IBIS Environmental Social Governance Consulting Africa (Pty) Ltd, Empowerdex, Internal Audit
UN Sustainable Development Goals
- SDG 3
- SDG 5
- SDG 6
- SDG 7
- SDG 8
- SDG 12
- SDG 13
- SDG 17
Aspen's initiatives contribute to these goals through actions aligned with material sustainability topics.
Sustainable Products & Innovation
- Eikance eye drops
Awards & Recognition
- 9th place in EY Excellence in Integrated Reporting Awards
- Transparency and Reporting Award in South African WEP Awards
- Finalist in Inclusive Workplace category in South African WEP Awards
- Economic Diplomacy (Global) Ubuntu Award
- Top Graduate Employer for the Pharmaceutical Sector in BP Students’ Choice Awards
- PMR.Africa Diamond Award
- President’s Manufacturer of the Year Award 2020
- Best on Corporate Sustainability Initiatives in Social Impact/CSR awards 2021
- Marketing Excellence Award
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Access to medicines
- Health security
- Patient safety
- Reliable supply of quality products
- Responsible advocacy
- Responsible marketing
- Responsible product portfolio
- Diversity, equity and inclusion
- Employee health and safety
- Employee well-being
- Fair compensation
- Labour rights
- Workforce development
- Compliance
- Corporate governance
- Data governance
- Economic value generated and distributed
- Ethical business culture
- Fair taxation
- Human rights
- Responsible supply chain management
- SED and investment in communities
- Transformation and economic inclusion (B-BBEE in South Africa)
- Climate change and greenhouse gas emissions
- Energy efficiency
- Resource use and waste
- Water and effluent
- Responsible advocacy
- Responsible supply chain management
- Biodiversity and abundance
- Health system strengthening
- Pharmaceuticals in the environment
- Product environmental stewardship
- Animal welfare
- Clinical trial conduct
Environmental Achievements
- Reduced Scope 1 emissions from 48,095 tCO2e in 2019 to 37,424 tCO2e in 2023
- Increased waste recycled from 58,821 tonnes in 2020 to 60,976 tonnes in 2023
- Achieved 86% waste recycled as a percentage of waste generated in 2023
Social Achievements
- Launched various SED projects supporting clinics, community upliftment, education and training, healthcare, and Mandela Day initiatives.
- Maintained a relatively stable average staff turnover rate around 14%.
Governance Achievements
- Maintained high governance and ethical standards, reflected in a FTSE/JSE Responsible Investment Index score of 3.6 in 2023.
- Incorporated sustainability KPIs into performance and incentive schemes.
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Not disclosed
Environmental Challenges
- Increased pricing of GHG emissions leading to increased operating costs.
- Increased stakeholder concern or negative feedback potentially reducing capital availability and revenue.
- Limited emission data on the supply chain (Scope 3 emissions).
Mitigation Strategies
- Climate scenario analysis conducted to understand potential cost impacts of carbon pricing.
- Development of a position statement on climate change and a climate strategy with short, medium, and long-term goals.
- Initiation of a supplier sustainability assessment program to develop a comprehensive Scope 3 emission profile.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Not disclosed
Climate-Related Risks & Opportunities
Physical Risks
- Flooding
- Increased prevalence of vector-borne diseases
Transition Risks
- Increased pricing of GHG emissions
- Increased stakeholder concern
- Limited Scope 3 emission data
Opportunities
- Energy efficiency improvements
- Resource conservation
Reporting Standards
Frameworks Used: GRI, SASB, TCFD, UNGC, JSE Sustainability Disclosure Guidance
Certifications: ISO 14001, ISO 45001, ISO 50001
Third-party Assurance: IBIS Environmental Social Governance Consulting Africa Proprietary Limited
UN Sustainable Development Goals
- SDG 3
Aspen's commitment to promoting access to high-quality, affordable medicines aligns with SDG 3: Ensuring healthy lives and promoting well-being for all at all ages.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed